Harbeck, N. Et Al. 2019. Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer. San Antonio Breast Cancer Symposium , (San-Antonio, Northern Mariana Islands).

Harbeck, N., Hurvitz, S., Bardia, A., Franke, F., Babu, K. G., Wheatley-Price, P., ... Im, Y.(2019). Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer . San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands

Harbeck, Nadia Et Al. "Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer," San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 2019

Harbeck, Nadia Et Al. "Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands, 2019

Harbeck, N. Et Al. (2019) . "Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands.

@conferencepaper{conferencepaper, author={Nadia Harbeck Et Al. }, title={Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer}, congress name={San Antonio Breast Cancer Symposium}, city={San-Antonio}, country={Northern Mariana Islands}, year={2019}}